Studies on the interaction between rhizospheres and non-rhizospheres of terrestrial plants are much more advanced, as evidenced by several scientific reports (Barea et al., 2013; Jurburg and Salles, ...

Novavax secures a non-exclusive licensing deal with Pfizer, validating Matrix-M's platform value and shifting NVAX toward a technology provider model. NVAX receives $30M upfront, a potential $500M in ...